ACS Infectious Diseases is a premier journal in the field of infectious diseases, published by the American Chemical Society. With an impressive Impact Factor that places it in the Q1 category for Infectious Diseases in 2023, the journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of infectious agents and their impact on public health. Established in 2015, the journal is committed to publishing cutting-edge research that enhances our understanding of infectious diseases and fosters the development of innovative interventions. Although not an open access journal, it provides a platform for high-quality research that influences policies and practices in the field. With an address located at 1155 16TH ST, NW, WASHINGTON, DC 20036, ACS Infectious Diseases is an authoritative voice in advancing the science and practice of infectious disease management.

International Journal of Antimicrobial Agents, published by Elsevier, stands as a premier platform in the fields of Infectious Diseases, Microbiology, and Medical Pharmacology. With an impressive impact factor and ranked in the Q1 category across multiple medical disciplines in 2023, this journal is recognized for its contribution to advancing knowledge and understanding in the efficacy and safety of antimicrobial treatments. Its comprehensive scope from 1991 to 2024 allows for the publishing of original research, reviews, and commentary on pressing issues related to antimicrobial resistance, treatment strategies, and pharmacological innovations. With a strong emphasis on high-quality research as reflected in its Scopus rankings, the journal is an essential resource for researchers, clinicians, and students dedicated to improving patient outcomes in the face of evolving microbiological challenges. Engage with the latest findings and methodologies through this vital academic resource, available in print and online, from the heart of the Netherlands.

Journal of Bone and Joint Infection, published by COPERNICUS GESELLSCHAFT MBH, is a pioneering open-access journal dedicated to the multidisciplinary field of bone and joint infections. Since its inception in 2016, it has served as a vital platform for researchers and practitioners to share cutting-edge findings, clinical practices, and innovative research methodologies from around the globe. Based in Germany, this journal has quickly established itself with a significant impact, currently holding a Q3 placement in Infectious Diseases and Q2 in both Orthopedics & Sports Medicine and Surgery, alongside commendable Scopus rankings. With the aim of advancing knowledge and fostering collaboration in the treatment and understanding of osteoarticular infections, the journal invites submissions that contribute to the scientific community's quest for effective management strategies and improved patient outcomes. The open-access format ensures that groundbreaking research is readily accessible, promoting wider dissemination and visibility within the community. As the Journal of Bone and Joint Infection continues through its converged years (2016-2024), it remains committed to supporting ongoing education and innovation in this critical area of medical research.

JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.

ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY, published by Springer, is a vital resource for advancing research in the fields of microbiology and molecular biology. With its ISSN 0003-6072 and E-ISSN 1572-9699, this journal consistently focuses on cutting-edge studies and developments, providing a platform for the dissemination of knowledge that spans over its rich history from 1934 onwards. The journal holds an impressive reputation, ranked Q2 in Medicine (miscellaneous) and Q3 in both Microbiology and Molecular Biology for 2023, reflecting its significant contribution to the scientific community. Researchers and professionals from various disciplines rely on this journal for quality publications that address complex microbial interactions and molecular mechanisms. Although it currently does not provide open access options, its compelling research remains accessible through institutional subscriptions, allowing it to foster collaborative advancements in the ever-evolving landscape of microbiological sciences.

The Lancet Microbe is a leading peer-reviewed journal published by ELSEVIER, focused on advancing research in the fields of infectious diseases, microbiology, and virology. Since its inception in 2020, this open-access journal has rapidly achieved a prestigious reputation, evidenced by its impressive rankings in the Scopus Ranks, where it holds positions within the top 10 in multiple categories and boasts high percentiles, reflecting the impact and relevance of its published works. With a quarterly publication schedule, the Lancet Microbe aims to disseminate critical findings and foster innovation within the scientific community, providing a platform for researchers and professionals to share their significant contributions. The journal is committed to facilitating knowledge exchange and accessibility, making it an essential resource for academicians and practitioners dedicated to addressing global health challenges.

The Revista Espanola de Quimioterapia, published by the SOCIEDAD ESPANOLA QUIMIOTERAPIA, is a pivotal open-access journal that has been advancing the field of clinical microbiology and pharmacology since its inception in 1989. With an E-ISSN of 1988-9518, this journal caters to a diverse audience of researchers, healthcare professionals, and students, providing them with critical insights into the latest developments in medicinal chemistry and therapeutic strategies. Located in Madrid, Spain, the journal reflects the rigorous academic standards of its associated institutions, contributing significantly to the translation of research into clinical practice. Achieving a Q3 ranking in the fields of Medicine, Microbiology, and Pharmacology in 2023 attests to its growing influence and relevance in the scientific community, making it a vital resource for those engaged in the quest for innovative solutions to pressing healthcare challenges. The journal prides itself on its commitment to maintaining an open-access model since 2018, ensuring that vital research is freely accessible to foster greater knowledge sharing and collaboration within the global scientific community.

FEMS Microbiology Letters, published by Oxford University Press, is a prestigious international journal dedicated to advancing the understanding of microbiology through concise and impactful research articles. With an ISSN of 0378-1097 and E-ISSN 1574-6968, this journal encompasses a wide range of topics within the fields of genetics, microbiology, and molecular biology, achieving a notable Q3 quartile ranking in these categories as of 2023. As an essential platform for researchers, professionals, and students, FEMS Microbiology Letters invites submissions that contribute valuable insights into microbial behaviors, genetic mechanisms, and innovative methodologies pivotal in the study of microbiology. Although it is not an open-access publication, the journal's rigorous editorial standards ensure high-quality content that is relevant and significant to its audience, furthering scholarly dialogue and collaboration in the vibrant field of microbiological research.

CURRENT MICROBIOLOGY, published by SPRINGER, is a renowned journal that serves as a critical platform for the dissemination of cutting-edge research in the field of microbiology. With an ISSN of 0343-8651 and an E-ISSN of 1432-0991, this journal contributes significantly to the scientific community by covering a diverse range of topics from applied microbiology and biotechnology to various aspects of medicine. Currently operating an impact factor that places it within the Q2 quartile in both applied microbiology and biotechnology and medicine (miscellaneous), along with a Q3 ranking in microbiology, CURRENT MICROBIOLOGY is recognized for its valuable contributions to these dynamic fields. This journal, which has documented the evolution of microbiological research since its inception in 1978, provides an essential venue for researchers, professionals, and students alike to explore innovative studies and advances. Although it does not offer open access, the journal remains a pivotal resource within its category, complementing the ongoing growth and exploration of microbiology from its headquarters at One New York Plaza, Suite 4600, New York, NY 10004, United States. Its Scopus rankings highlight its reputable standing, making it a key publication for anyone aiming to stay at the forefront of microbiological science.

HELICOBACTER is a leading peer-reviewed journal published by Wiley, dedicated to advancing the field of gastroenterology and infectious diseases. With an impressive impact factor that places it in the Q1 quartile across three critical categories—gastroenterology, infectious diseases, and miscellaneous medicine—it signifies the journal's crucial role in disseminating high-quality research and fostering academic dialogue. Commencing publication in 1996, HELICOBACTER has established itself as a pivotal platform for innovative studies, case reports, and reviews, focusing on Helicobacter species and their clinical implications, thus attracting a global audience of researchers, healthcare professionals, and students eager to stay at the forefront of the field. Despite not being an open-access journal, its strong reputation is reinforced by its Scopus ranks, where it stands impressively at #19 out of 167 in gastroenterology, placing it in the 88th percentile among its peers. As a vital resource for those engaged in gastrointestinal and infectious research, HELICOBACTER continues to contribute significantly to the understanding and management of Helicobacter-related conditions.